GLP-1 pills are coming, and they could revolutionize weight-loss
WEBSep 17, 2024 — Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience. But she and other doctors also warn about the potential for misuse, a...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
WEBJune 23, 2024, 5:46 PM UTC. By Berkeley Lovelace Jr. The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo...
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
WEBMay 21, 2024 — An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
WEBOct 30, 2023 — Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
WEBAug 12, 2024 — Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
Experimental drug could offer more weight loss than any drug ... - NBC News
WEBJun 26, 2023 — The new study underscores the rapid upswing in recent years in the discovery of new treatments for weight loss as companies invest in a new class of medicines called GLP-1 agonists, which mimic a...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEBThe FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight.
1 in 8 adults in the US has taken Ozempic or another GLP-1 drug ... - CNN
WEBMay 10, 2024 — About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people – are...
Research shows GLP-1 drugs are effective but complex
WEBMay 30, 2024 — While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment.
New GLP-1 weight loss drug Zepbound approved by FDA: What …
WEBNov 14, 2023 — Eli Lilly's new obesity medication Zepbound (tirzepatide) recently received FDA approval. Experts explain how the GLP-1 drug works and compares to similar drugs.